China has cut value-added tax (VAT) to 3% on imports, production and sales of the second batch of anti-cancer and rare diseases drugs in a bid to lower costs for patients and boost its pharmaceutical industry, customs said on Thursday.
Source: todayonline.com
Latest Posts in "China"
- China’s New VAT Refund Policy for Taxpayers Begins September 2025
- China Expands Consumption Tax to Include More Ultra-Luxury and New Energy Vehicles
- China Expands VAT Refunds for Tourists, Jilin Province Joins Scheme from September 2025
- China Introduces New VAT Refund Policy for End-of-Period Tax Credits Starting September 2025
- China’s Major VAT Credit Refund Policy Adjustments: What Businesses Need to Know
